Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and ...

Traders should book partial profits during rallies and using tight trailing stop-losses, which will help manage risk ...

Everest Medicines (HKEX: 1952.HK), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative medicines, recently hosted the '2025 ...

Strategic consultancy firm Eight Advisory has today published the third edition of their Takeup Tracker, which examines the ...

Nissan is recalling certain cars in the U.S. and Canada because of a possible problem with engine bearings in some VC-Turbo ...